CONSIDERATIONS TO KNOW ABOUT BLOCK PAIN RECEPTORS WITH PROLEVIATE

Obtaining discovered the palmitoylation motif of APLNR, we designed a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This competitive peptide, which targets the APLNR palmitoylation web site together with morphine, can inhibit the development of NCP, like pain incidence, microglial activation, and inflamma